Umbilical cord tissue mesenchymal stem cells: Characterization and clinical applications

Current Stem Cell Research and Therapy

Volumn 8, Issue 5, 2013, Pages 394-399

  Harris, David T ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Cord tissue; Mesenchymal stem cells; Regenerative medicine; Stem cells; Tissue engineering

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARTILAGE INJURY; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL THERAPY; EYE DISEASE; FRACTURE HEALING; GRAFT VERSUS HOST REACTION; HUMAN; JOINT INJURY; LIGAMENT AND TENDON INJURY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SPINAL CORD INJURY; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE CHARACTERIZATION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUES; UMBILICAL CORD; UMBILICAL CORD BLOOD; UMBILICAL CORD TISSUE; CYTOLOGY; FETUS BLOOD; MESENCHYMAL STROMA CELL; PROCEDURES; STEM CELL TRANSPLANTATION;

FETAL BLOOD; HUMANS; MESENCHYMAL STROMAL CELLS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; UMBILICAL CORD;

EID: 84888194005     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308050006     Document Type: Article

References (103)

1. Broxmeyer HE, Gluckman E, Auerbach A, et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 1990, 8 (Suppl 1): 76-89; discussion 89-91.
2. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321(17): 1174-8.
3. Gluckman E. Stem cell harvesting from cord blood: A new perspective. In: Wunder, H.a. (ed.) Peripheral Blood Stem Cell Autographs. Springer Verlag, (1990).
4. Broxmeyer HA, Kurtzberg J, Gluckman E, et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation: An expanded role for cord blood transplantation. Blood Cells 1991, 17 (2): 330-7.
5. Broxmeyer HE, Kurtzberg J, Gluckman E, et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 1991; 17(2): 313-29.
6. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. ProcNatlAcadSci USA 1989; 86(10): 3828-32.
7. Vilmer E, Sterkers G, Rahimy C, et al. HLA-mismatched cordblood transplantation in a patient with advanced leukemia. Transplantation 1992; 53 (5): 1155-7.
8. Wagner JE, Kernan NA, Steinbuch M, et al. Allogeneic sibling umbilical cord blood transplantation in children with malignant and nonmalignant disease. Lancet 1995, 346: 214-19.
9. Butler MG, Menitove JE. Umbilical cord blood banking: an update. J Assist Reprod Genet 2011; 28 (8): 669-76.
10. McGuckin C, Forraz N, Baradez MO, et al. Production of stem cells with embryonic characteristics from human umbilical cord blood.Cell Prolif 2005, 38: 245-55.
11. McGuckin CP, Forraz N, Allouard Q, Pettengell R. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp Cell Res 2004; 295: 350-9.
12. Rogers I, Yamanaka N, Bielecki R, et al. Identification and analysis of in vitro cultured CD45-positive cells capable of multi-lineage differentiation. Exp Cell Res 2007; 313: 1839-52.
13. Kucia M, Halasa M, Wysoczynski M, et al. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human umbilical cord blood-preliminary report. Leukemia 2007; 21: 297-303.
14. Harris DT, He X, Badowski M, Nichols JC. Regenerative Medicine of the Eye: A Short Review. Stem Cell Repair & Regeneration, Vol. 3, Levicar N, Habib NA, Dimarakis I, Gordon MY (Ed.s), Imperial College Press, p. 211-225, London (2008).
15. Sunkomat, J.N.E., Goldman, S., & Harris, D.T. Cord blood-derived MNCs delivered intracoronary contribute differently to vascularization compared to CD34+ cells in the rat model of acute ischemia. J Mol Cell Cardiol 2007; 42(6): Suppl 1: S97.
16. Choudhery MS, Badowski M, Muise A, Harris DT. Comparison of the Regenerative Potential of Human Adipose and Cord Tissue Derived Mesenchymal Stem Cells, Cytotherapy 2013; 15: 330-43.
17. Perry D. Patient's voices: the powerful sound in the stem cell debate. Science 2000; 287: 1423.
18. Harris DT. Non-Haematological Uses of Cord Blood Stem Cells. Br J Haematol 2009; 147: 177-84.
19. Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2007; 2: 301-9.
20. www.clinicaltrials.gov
21. Harris DT, Badowski M, Ahmad N, Gaballa, M. The Potential of Cord Blood Stem Cells for Use in Regenerative Medicine. Expert Opin Biol Ther 2007; 7(9): 1311-22.
22. Xue G, He M, Zhao J, et al. Intravenous umbilical cord mesenchymal stem cell infusion for the treatment of combined malnutrition nonunion of the humerus and radial nerve injury. Regen Med 2011; 6: 733-41.
23. Wu KH, Chan CK, Tsai C, et al. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 2011; 91(12): 1412-16.
24. Liang J, Zhang H, Hua B, et al. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. MultScler 2009; 15(5):644-6.
25. Liang J, Gu F, Wang H, et al. Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol 2010; 6(8): 486-9.
26. Reza HM, Ng B-Y, Gimeno FL, Phan TT, Ang LP-K. Umbilical Cord Lining Stem Cells as a Novel and Promising Source for Ocular Surface Regeneration. Stem Cell Rev and Rep 2011; 7: 935-47.
27. Huang Y-C, Parolini O, La Rocca G, Deng L. Umbilical cord versus bone marrow-derived mesenchymal stromal cells. Stem Cells Dev 2012; 21: 2900-03.
28. Zhang X, Hirai M, Cantero S, et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: Reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cellular Biochem 2011; 112: 1206-18.
29. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal stem cells but umbilical cord and mobilized blood adult blood are not. Br J Haematol 2003; 121: 368-74.
30. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669-75.
31. Musina RA, Bekchanova ES, Belyavskii AV, Grinenko TS, Sukhikh GT. Umbilical cord blood mesenchymal stem cells. Bull Exp Biol Med 2007; 143: 127-31.
32. Secco M, Zucconi E, Vieira NM, et al. Multipotentstem cells from umbilical cord: cord is richer than blood. Stem Cells 2008; 26: 146-50.
33. William PL, Banister LH, Berry MM, et al. Grays anatomy (38th ed. London: ELBS Churchill Livingstone; (1995).
34. Bongso A, Fong C-Y. The therapeutic potential, challenges and future clinical directions of stem cells from Wharton's jelly of the human umbilical cord. Stem Cell Rev Rep. DOI 10.1007/s12015-012-9418-z
35. Jeschke MG, Gauglitz GG, Phan TT, Herndon DN, Kita K. Umbilical cord lining membrane and Wharton's jelly-derived mesenchymal stem cells: the similarities and differences. Open Tissue Eng Regen Med J 2011; 4: 21-7.
36. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006; 24: 781-92.
37. Seshareddy K, Troyer D, Weiss ML. Methods to isolate mesenchymal-like cells from Wharton's jelly of umbilical cord. Methods Cell Biol 2008; 86: 101-19.
38. Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's Jelly of the human umbilical cord. Stem Cells 2004; 22: 1330-7.
39. Fong CY, Richards M, Manasi N, Biswas A, Bongso A. Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reproductive Biomedicine Online, 2007, 15: 708-718.
40. Fong CY, Gauthaman K, Bongso A. Reproductive stem cells of embryonic origin: comparative properties and potential benefits of human embryonic stem cells and Wharton's jelly stem cells. In C. Simon & A. Pellicer (Eds.), Stem cells in human reproduction (2nd ed., pp. 136-149). New York: InformaHealthcare (2009).
41. Fong CY, Subramanian A, Biswas A, et al. Derivation efficiency, cell proliferation, frozen-thaw survival, 'stemness' properties, and differentiation of human Wharton's jelly stem cells: their potential for concurrent banking with cord blood for regenerativemedicine purposes. Reprod Biomed Online 2010; 21: 391-401.
42. Angelucci S, Marchisio M, Giuseppe FD, Pierdomenico L, Sulpizio M, Eleuterio E. Proteome analysis of human Wharton's jelly cells during in vitro expansion. Proteome Sci 2010; 8: 18-25.
43. Ding DC, Shyu WC, Lin SZ, Liu HW, Chiou SH, Chu TY. Human umbilical cord mesenchymal stem cells support non-tumorigenic expansion of human embryonic stem cells. Cell Transplant 2012; 21(7): 1515-27.
44. Kikuchi-Taura A, Taguchi A, Kanda T, et al. Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells. Cytotherapy 2012; 14: 441-50.
45. Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesissupportive function and other potentials. Haematologica 2006; 91: 1017-26.
46. Schugar RC, Chirieleison SM, Wescoe KE, et al. High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol 2009; 2009: 789526.
47. Capelli C, Gotti E, Morigi M, et al. Minimally manipulated whole human umbilical cord is a rich source of clinical grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy 2011; 13: 786-801.
48. Bosch J, Houben AP, Radke TF, et al. Distinct differentiation potential of 'MSC' derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells? Stem Cells Dev 2012; 21(11): 1977-88.
49. Kita K, Gauglitz GG, Phan TT, Herndon DN, Jeschke MG. Isolation and characterization of mesenchymal stemcells from the sub amniotic human umbilical cord lining membrane. Stem Cells Dev 2010; 19: 491-502.
50. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005; 23: 220-9.
51. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21: 105-10.
52. Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 2007; 25: 319-31.
53. Fu YS, Shih YT, Cheng YC, Min MY. Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci 2004; 11: 652-60.
54. Tsagias N, Koliakos I, Karagiannis V, Eleftheriadou M, Koliakis GG. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Transfusion Med 2011; 21: 253-61
55. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-17.
56. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 2008, 15(2): 109-16.
57. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726-36.
58. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3: 393-403.
59. Bieback K, Kern S, Kocaomer A, Ferlik K, Bugert P. Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng 2008; 18(1 Suppl): S71-76.
60. Prather WR, Toren A, Meiron M, Ofir R, Tschope C, Horwitz EM. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia.Cytotherapy. 2009; 11(4): 427-34.
61. Jo CH, Kim OS, Park EY, et al. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell Tissue Res 2008; 3: 423-33.
62. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells; 2008, 26(3): 591-9.
63. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 2009; 4(3): 423-33.
64. Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007; 25(11): 2886-95.
65. Fan C-G, Zhang Q-J, Zhou J-R. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev Rep 2011; 7: 195-207.
66. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells characteristics and clinical applications. Folia HistochemCytobiol 2006; 44(4): 215-30.
67. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, Fu YS. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS ONE 2008; 3(10): e3336.
68. Liao W, Xie J, Zhong J, et al. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 2009; 87(3): 350-9.
69. Liao W, Zhong J, Yu J, et al. Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cell PhysiolBiochem 2009; 24(3-4): 307-16.
70. Koh SH, Kim KS, Choi MR, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008; 1229: 233-48.
71. Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24(3): 781-92.
72. Ishikane S, Ohnishi S, Yamahara K, et al. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 2008; 26(10): 2625-33.
73. Bailey MM, Wang L, Bode CJ, Mitchell KE, Detamore MS. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 2007; 13(8): 2003-10.
74. Wu LF, Wang NN, Liu YS, Wei X. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. Tissue Eng Part A 2009 15(10): 2865-73.
75. ClinicalTrials.govMesenchymal Stem Cell. http://www.clinicaltrials.gov/ct2/results?intr=mesenchymal+stem+cell. Accessed December 1st, 2011.
76. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Agerelated osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14 (7): 1115-22.
77. Tokalov SV, Gruner S, Schindler S, Wolf G, Baumann M, Abolmaali N. Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells & Develop 2007; 16: 439-46.
78. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mechanisms Aging & Develop 2008; 129: 163-73.
79. Bonyadi M, Waldman SD, Liu D, Aubin JE, Grynpas MD, Stanford SL. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA 2003; 100(10): 5840-5.
80. Stolzing A, Scutt A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell 2006; 5 (3): 213-24.
81. Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002; 46 (3): 704-13.
82. Zhang H, Fazel S, Tian H, et al. Increasing donor age adversely impacts beneficial effects of bone marrow but no smooth muscle myocardial cell therapy. Am J Physiol, Heart & Circ. Physiol 2005; 289(5): H2089-96.
83. Kretlow JD, Jin YQ, Liu W, et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biology 2008,http://www.biomedcentral.com/1471-2121/9/60.
84. http://ClinicalTrials.govwebsite
85. Preynat-Seauve O, Krause KH. Stem cell sources for regenerative medicine: the immunological point of view. Semin Immunopathol 2011; 33(6): 519-24.
86. Badowski, MS and DT Harris. Collection, Processing and banking of umbilical cord blood stem cells for transplantation and regenerative medicine. In: Somatic Stem Cells: Methods and Protocols, Methods in Molecular Biology, SR Singh (Ed), Humana Press+Springer Science, 2012; 879: 279-90.
87. www.arthritis.org. Accessed December 1st, 2011
88. Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005; 33: 1402-16.
89. Germain L, Auger FA, Grandbois E, et al. Boisjoly, H. & Guerin, S. L. Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology 1999; 67: 140-7.
90. Germain L, Carrier P, Auger FA, Salesse C, Guerin SL. Can we produce a human corneal equivalent by tissue engineering? Progress Retinal Eye Research 2000; 19(5): 497-527.
91. Zhang L, Li Y, Zhang C, Chopp M, Gosiewska A, Hong K. Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 2011; 42: 1437-44
92. Hess DC, Borlongan CV. Cell-based therapy in ischemic stroke. Expert Review of Neurotherapeutics 2008; 8(8): 1193-201.
93. Ding DC, Shyu WC, Chiang MF, et al. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis 2007; 27(3): 339-53.
94. Koh SH, Kim KS, Choi MR, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008; 1229: 233-48.
95. Liao W, Zhong J, Yu J, et al. Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cell Physiol Biochem 2009; 24(3-4): 307-16.
96. Lim JH, Byeon YE, Ryu HH, et al. Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J Vet Sci 2007; 8(3): 275-82
97. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, Fu YS. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS ONE 2008; 3(10): e3336.
98. Zhang L, Zhang HT, Hong SQ, Ma X, Jiang XD, Xu RX. Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection. Neurochem Res 2009; 34(11): 2030-9.
99. Hu SL, Luo HS, Li JT, et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells. Crit Care Med 2010; 38(11): 2181-9.
100. Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006; 24(3): 781-92.
101. Fu YS, Cheng YC, Lin MY, et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 2006; 24(1): 115-24
102. Lindenmair A, Hatlapatka T, Kollwig G, et al. Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. Cells 2012; 1: 1061-88.
103. Gonzalo-Daganzo R, Regidor C, Martin-Donaire T, et al. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 2009; 11(3): 278e88.